Who
David Russell Gaugh
Director
Company insider
Files Form 4 as: Director, Amphastar Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 18 Jul 2025
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —8,143 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,365 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,365 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —8,143 at $0.00 | filing |
| 18 Jul 2025filed 22 Jul 2025 | AMPH Amphastar Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —13,987 at $0.00 | filing |
| 18 Jul 2025filed 22 Jul 2025 | AMPH Amphastar PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —6,304 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.